Clinical Trials Logo

Post-Traumatic Headache clinical trials

View clinical trials related to Post-Traumatic Headache.

Filter by:

NCT ID: NCT03385889 Completed - Clinical trials for Musculoskeletal Neck Pain

Effects of Cervical Manual Therapy on Cervicogenic Headache

Start date: February 15, 2018
Phase: N/A
Study type: Interventional

The effects of cervical spine manual therapy, including mobilization and manipulation, on cervical spine range of motion, joint position sense, and balance is unknown among individuals with cervicogenic headache. Previous studies have indicated improved frequency of headache, decreased perceived disability, and demonstrated improved neuromuscular function following upper cervical manipulation. Other authors report improved cervical spine range of motion, joint position sense, and balance following cervical spine manual therapy for individuals with cervicogenic dizziness. Through an experimental design, this study aims to determine the effects of cervical spine manual therapy on variables such as cervical spine range motion, joint position sense, and balance among individuals with headache of a cervical spine origin.

NCT ID: NCT03347188 Completed - Clinical trials for Post-Traumatic Headache

A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)

Start date: December 18, 2017
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of fremanezumab in adult participants aged 18 to 70 years, inclusive, for the prevention of PTH. The study will include a double-blind (DB) treatment period (12 weeks) and an open-label (OL) treatment period (12 weeks).

NCT ID: NCT03220958 Completed - Clinical trials for Post-Traumatic Headache

Metoclopramide for Post Traumatic Headache

Start date: August 1, 2017
Phase: Phase 3
Study type: Interventional

Nearly 1.5 million patients present to US emergency departments annually following head trauma. Headache is a frequent symptom of victims of head trauma. The purpose of this study is to see if an intravenous medication called metoclopramide can improve the symptoms of patients with acute post-traumatic headache.

NCT ID: NCT03113357 Completed - Clinical trials for Cervicogenic Headache

The Effect of Myofascial Release in Patients With Cervicogenic Headache

RCT
Start date: January 2015
Phase: N/A
Study type: Interventional

Cervicogenic headache (CeH) is a secondary and often unilateral that is known by referring pain from soft or hard cervical structures to occipital, temporal, frontal and sometimes pre-orbital regions. There is higher prevalence of cervical muscle tightness, assessed clinically in CeH patients and anatomically there are some fascial connections between sub-occipital muscles with vertebra of C2 and Dura-mater.Therefore fascial restriction in this region can limit the normal movement of muscles between fascial plates in different directions in sub-occipital region. The purpose of current study was to compare the effect of MFR Technique in the upper cervical region with common (Exs) on pain intensity, frequency, duration and Pressure Pain Threshold (PPT) of upper cervical joints in subjects with CeH.

NCT ID: NCT03056352 Completed - Clinical trials for Post-Traumatic Headache

Metoclopramide for Post-Traumatic Headache. A Pilot Study

Start date: March 1, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

Post-traumatic headache is common. We are determining short and longer-term outcomes among patients treated for post-traumatic headache with IV metoclopramide.

NCT ID: NCT02965027 Completed - Clinical trials for Post-Traumatic Headache

Prazosin for Post-Concussive Headaches

Start date: November 29, 2016
Phase: Phase 4
Study type: Interventional

Mild traumatic brain injury (mTBI) caused by blast effects of explosive devices has been called the "signature injury" of soldiers who served in the Iraq and Afghanistan conflicts. mTBI can also occur from impact or hitting the head on an object or the ground. Although termed "mild" in comparison to major brain injuries, people with mTBI can have problems with their memory and concentration. People with mTBI can also find they are more irritable, have more anxiety, and have trouble with their mood and sleep. The purpose of this study is to see if a medication called prazosin can help treat chronic headaches in people with mTBI. The Food and Drug Administration (FDA) has approved prazosin for treating people with high blood pressure. At this time, the FDA has not approved prazosin in the treatment of mTBI or headaches. Some people who have posttraumatic stress disorder (PTSD) and have been taking prazosin for their medical conditions or who have taken it in research studies have said they have fewer headaches.

NCT ID: NCT02708953 Completed - Clinical trials for Headache Disorders, Secondary

Thoracic Spine Thrust Manipulation for Cervicogenic Headaches: A Randomized Clinical Trial

Start date: May 2016
Phase: N/A
Study type: Interventional

Headaches have been listed as 1 of the 10 most disabling conditions worldwide. (Stovner et al., 2007) and cervicogenic headaches (CeHs) comprise 15% of the individuals with these complaints. (Nillsson, 1995); (Fernandez de-las-penas et al., 2005) The current best approach to the conservative care of this condition has yet to be determined. The primary aim of this study is to determine whether individuals with CeHs will respond to a program of thoracic spine thrust manipulation in isolation. This may further the current body of evidence by offering an alternative, potentially safer approach to the conservative care of individuals with this condition. Additionally, results of this study may serve to drive a larger scale Randomized Clinical Trial (RCT) by offering information regarding feasibility of recruitment of individuals with chronic CeHs as well as timing and dosing of the intervention.

NCT ID: NCT02419131 Completed - PTSD Clinical Trials

Cognitive-Behavior Therapy for Posttraumatic Headache

Start date: May 1, 2015
Phase: N/A
Study type: Interventional

The overall purpose of the study is to compare two talk therapies (Clinic-Based Cognitive Behavioral Therapy and Cognitive Processing Therapy-Cognitive Only) for the treatment of posttraumatic headache (PTHA) and co-morbid posttraumatic stress (PTS). The researchers hope to learn if a non-medication, cognitive-behavioral treatment can result in noticeable reductions in PTHA intensity/severity and frequency as well as PTS symptom severity.

NCT ID: NCT02373605 Completed - Clinical trials for Cervicogenic Headaches

Spinal Manipulation and Dry Needling Versus Conventional Physical Therapy in Patients With Cervicogenic Headache

Start date: February 2015
Phase: N/A
Study type: Interventional

The purpose of this research is to compare two different approaches for treating patients with cervicogenic headaches: non-thrust mobilization and exercise versus thrust manipulation and dry needling. Physical therapists commonly use all of these techniques to treat cervicogenic headaches. This study is attempting to find out if one treatment strategy is more effective than the other.

NCT ID: NCT02266329 Completed - Headache Clinical Trials

Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin

Start date: January 4, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if prazosin is more effective than placebo in decreasing frequency, severity, disability, and other negative effects of headaches related to mild traumatic brain injury in Service Members and Veterans.